Compliance and Responsible Operations
Dawn Therapeutics is committed to high standards of scientific integrity, confidentiality, governance, and responsible partnerships. This page outlines the practical compliance principles we apply across research, collaboration, and business operations.
Quick actions
Use the links below for policy requests, due diligence enquiries, or compliance related questions.
Core compliance pillars
Operational foundationCorporate governance
Clear accountability, documented decision making, and responsible oversight across scientific, operational, and partner activities.
Scientific integrity
Accurate records, transparent reporting, reproducible workflows, and disciplined review of preclinical data and technical claims.
Data privacy and security
Controlled access, proportionate data handling, and privacy aware communications for partners, institutions, and professional contacts.
Confidentiality and IP protection
Information sharing on a need to know basis with NDA supported discussions, version control, and protected disclosure pathways.
Anti bribery and conflicts
Zero tolerance for improper payments or inducements, with conflict disclosure expectations for employees, advisors, and partners.
Third party due diligence
Risk based screening and onboarding for suppliers, consultants, CROs, and strategic collaborators before sensitive engagement.
How compliance is applied in practice
Execution workflowScreen and scope
We define the purpose of each collaboration or vendor engagement, identify the risk profile, and confirm what information can be shared at the initial stage.
Confidentiality controls
Where appropriate, discussions move forward under NDA with clear boundaries on data use, disclosure, and onward sharing.
Due diligence and documentation
We collect essential corporate and operational details, check fit for purpose, and maintain organised records of material communications and approvals.
Role based access
Information access is limited to relevant team members and partners, with practical controls for sensitive scientific, commercial, and IP materials.
Ongoing review and escalation
Concerns are raised early, reviewed promptly, and escalated to the appropriate internal lead for remediation or policy action.
Audit trail and improvement
We maintain traceability for key decisions and update procedures as the company, partnerships, and regulatory expectations evolve.
Partner and supplier expectations
Working with Dawn- Accurate company and contact information
- Clear scope of work and deliverables
- Respect for confidentiality and IP boundaries
- Conflict disclosure where relevant
- Secure handling of shared materials
- Named project owner and escalation contact
- Version controlled documents and approvals
- Meeting notes with action tracking
- Timely reporting of risks or delays
- Professional and respectful communication
Detailed technical, patent, and commercial materials are typically shared in stages and only where justified by the discussion stage, partner profile, and confidentiality arrangements.
Policy library and governance documents
Request based accessContact compliance or submit a concern
Secure and professional enquiriesWhat happens after submission
Compliance related messages are reviewed and routed to the appropriate internal lead. Depending on the nature of the enquiry, Dawn may respond with clarifying questions, secure sharing steps, or a policy summary.
- General policy and process questions can be answered directly
- Confidential matters may require NDA or secure follow up channel
- Partner due diligence requests may need supporting documents
- Reported concerns are handled with care and timely escalation
